Global Integrated Multi-Omics Services Supply, Demand and Key Producers, 2026-2032
The global Integrated Multi-Omics Services market size is expected to reach $ 3109 million by 2032, rising at a market growth of 12.1% CAGR during the forecast period (2026-2032).
Integrated Multi-Omics Services refer to professional technical services that systematically integrate and analyze data from multiple omics disciplines, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, through advanced bioinformatics pipelines, computational technologies and statistical methods, which aim to break the limitations of single-omics analysis, reveal the interactions and regulatory mechanisms among different molecular layers, and provide a comprehensive and in-depth understanding of biological systems, health status and disease mechanisms for researchers, pharmaceutical enterprises, medical institutions and other clients, with the flexibility to customize solutions according to specific research or application needs.
The demand for Integrated Multi-Omics Services is growing rapidly driven by multiple factors: the increasing complexity of biological research and clinical diagnosis requires a holistic analytical approach to make up for the shortcomings of single-omics analysis, the booming development of precision medicine and AI drug discovery has boosted the demand for multi-omics data integration to identify biomarkers and therapeutic targets, and the continuous decline in sequencing costs and the maturity of AI and cloud computing technologies have made multi-omics analysis more accessible for academic institutions, pharmaceutical companies and agricultural institutions; corresponding business opportunities are prominent, as the global multi-omics services market is projected to grow at a high compound annual growth rate, with North America as the largest market and the Asia-Pacific region as the fastest-growing market, and key opportunities lie in customized service development for oncology, neurological disorders and other fields, integration of AI and machine learning into analysis workflows, expansion of application scenarios in agricultural breeding and environmental monitoring, and provision of one-stop solutions including data collection, analysis and interpretation to meet the diverse needs of different end-users.
This report studies the global Integrated Multi-Omics Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Integrated Multi-Omics Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Integrated Multi-Omics Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Integrated Multi-Omics Services total market, 2021-2032, (USD Million)
Global Integrated Multi-Omics Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Integrated Multi-Omics Services total market, key domestic companies, and share, (USD Million)
Global Integrated Multi-Omics Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Integrated Multi-Omics Services total market by Omics Integration Type, CAGR, 2021-2032, (USD Million)
Global Integrated Multi-Omics Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Integrated Multi-Omics Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient, Bruker Spatial Biology CRO Services, Advanced Cell Diagnostics (ACD), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Integrated Multi-Omics Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Omics Integration Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Integrated Multi-Omics Services Market, By Region:
1. How big is the global Integrated Multi-Omics Services market?
2. What is the demand of the global Integrated Multi-Omics Services market?
3. What is the year over year growth of the global Integrated Multi-Omics Services market?
4. What is the total value of the global Integrated Multi-Omics Services market?
5. Who are the Major Players in the global Integrated Multi-Omics Services market?
6. What are the growth factors driving the market demand?
Integrated Multi-Omics Services refer to professional technical services that systematically integrate and analyze data from multiple omics disciplines, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, through advanced bioinformatics pipelines, computational technologies and statistical methods, which aim to break the limitations of single-omics analysis, reveal the interactions and regulatory mechanisms among different molecular layers, and provide a comprehensive and in-depth understanding of biological systems, health status and disease mechanisms for researchers, pharmaceutical enterprises, medical institutions and other clients, with the flexibility to customize solutions according to specific research or application needs.
The demand for Integrated Multi-Omics Services is growing rapidly driven by multiple factors: the increasing complexity of biological research and clinical diagnosis requires a holistic analytical approach to make up for the shortcomings of single-omics analysis, the booming development of precision medicine and AI drug discovery has boosted the demand for multi-omics data integration to identify biomarkers and therapeutic targets, and the continuous decline in sequencing costs and the maturity of AI and cloud computing technologies have made multi-omics analysis more accessible for academic institutions, pharmaceutical companies and agricultural institutions; corresponding business opportunities are prominent, as the global multi-omics services market is projected to grow at a high compound annual growth rate, with North America as the largest market and the Asia-Pacific region as the fastest-growing market, and key opportunities lie in customized service development for oncology, neurological disorders and other fields, integration of AI and machine learning into analysis workflows, expansion of application scenarios in agricultural breeding and environmental monitoring, and provision of one-stop solutions including data collection, analysis and interpretation to meet the diverse needs of different end-users.
This report studies the global Integrated Multi-Omics Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Integrated Multi-Omics Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Integrated Multi-Omics Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Integrated Multi-Omics Services total market, 2021-2032, (USD Million)
Global Integrated Multi-Omics Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Integrated Multi-Omics Services total market, key domestic companies, and share, (USD Million)
Global Integrated Multi-Omics Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Integrated Multi-Omics Services total market by Omics Integration Type, CAGR, 2021-2032, (USD Million)
Global Integrated Multi-Omics Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Integrated Multi-Omics Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient, Bruker Spatial Biology CRO Services, Advanced Cell Diagnostics (ACD), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Integrated Multi-Omics Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Omics Integration Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Integrated Multi-Omics Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dual-Omics Integration Services
- Triple-Omics Integration Services
- Quadruple & Above Multi-Omics Integration Services
- NGS-Based Integration Services
- MS-Based Integration Services
- Bioinformatics Software-Assisted Services
- Others
- Sample Preparation & Sequencing Services
- Data Integration & Analysis Services
- Result Interpretation & Report Services
- Customized Solution Design Services
- Others
- Disease Research
- Precision Medicine
- Crop Breeding
- Environmental Microbial Monitoring
- Others
- Azenta Life Sciences
- Eurofins
- Source BioScience
- Psomagen
- Tempus
- Evotec
- Crown Bioscience
- Sapient
- Bruker Spatial Biology CRO Services
- Advanced Cell Diagnostics (ACD)
- Panome Bio
- RayBiotech
- Metware Biotechnology
- HaploX
- Creative Proteomics
- CD Genomics
- Omics Empower
- Cmbio
- Dalton Bioanalytics
- General Metabolics
- Signios Bio
- Source Genomics
- Genechem
- BGI Genomics
- OE Biotech
- BMKGENE
- Majorbio
- Wayen Biotechnologies
1. How big is the global Integrated Multi-Omics Services market?
2. What is the demand of the global Integrated Multi-Omics Services market?
3. What is the year over year growth of the global Integrated Multi-Omics Services market?
4. What is the total value of the global Integrated Multi-Omics Services market?
5. Who are the Major Players in the global Integrated Multi-Omics Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Integrated Multi-Omics Services Introduction
1.2 World Integrated Multi-Omics Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Integrated Multi-Omics Services Total Market by Region (by Headquarter Location)
1.3.1 World Integrated Multi-Omics Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.3 China Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.4 Europe Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.5 Japan Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.6 South Korea Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.8 India Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Integrated Multi-Omics Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Integrated Multi-Omics Services Consumption Value (2021-2032)
2.2 World Integrated Multi-Omics Services Consumption Value by Region
2.2.1 World Integrated Multi-Omics Services Consumption Value by Region (2021-2026)
2.2.2 World Integrated Multi-Omics Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Integrated Multi-Omics Services Consumption Value (2021-2032)
2.4 China Integrated Multi-Omics Services Consumption Value (2021-2032)
2.5 Europe Integrated Multi-Omics Services Consumption Value (2021-2032)
2.6 Japan Integrated Multi-Omics Services Consumption Value (2021-2032)
2.7 South Korea Integrated Multi-Omics Services Consumption Value (2021-2032)
2.8 ASEAN Integrated Multi-Omics Services Consumption Value (2021-2032)
2.9 India Integrated Multi-Omics Services Consumption Value (2021-2032)
3 WORLD INTEGRATED MULTI-OMICS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Integrated Multi-Omics Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Integrated Multi-Omics Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Integrated Multi-Omics Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Integrated Multi-Omics Services in 2025
3.3 Integrated Multi-Omics Services Company Evaluation Quadrant
3.4 Integrated Multi-Omics Services Market: Overall Company Footprint Analysis
3.4.1 Integrated Multi-Omics Services Market: Region Footprint
3.4.2 Integrated Multi-Omics Services Market: Company Product Type Footprint
3.4.3 Integrated Multi-Omics Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Integrated Multi-Omics Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Integrated Multi-Omics Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Integrated Multi-Omics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Integrated Multi-Omics Services Consumption Value Comparison
4.2.1 United States VS China: Integrated Multi-Omics Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Integrated Multi-Omics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Integrated Multi-Omics Services Companies and Market Share, 2021-2026
4.3.1 United States Based Integrated Multi-Omics Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Integrated Multi-Omics Services Revenue, (2021-2026)
4.4 China Based Companies Integrated Multi-Omics Services Revenue and Market Share, 2021-2026
4.4.1 China Based Integrated Multi-Omics Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Integrated Multi-Omics Services Revenue, (2021-2026)
4.5 Rest of World Based Integrated Multi-Omics Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Integrated Multi-Omics Services Revenue (2021-2026)
5 MARKET ANALYSIS BY OMICS INTEGRATION TYPE
5.1 World Integrated Multi-Omics Services Market Size Overview by Omics Integration Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Omics Integration Type
5.2.1 Dual-Omics Integration Services
5.2.2 Triple-Omics Integration Services
5.2.3 Quadruple & Above Multi-Omics Integration Services
5.3 Market Segment by Omics Integration Type
5.3.1 World Integrated Multi-Omics Services Market Size by Omics Integration Type (2021-2026)
5.3.2 World Integrated Multi-Omics Services Market Size by Omics Integration Type (2027-2032)
5.3.3 World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type (2027-2032)
6 MARKET ANALYSIS BY TECHNICAL TOOL
6.1 World Integrated Multi-Omics Services Market Size Overview by Technical Tool: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technical Tool
6.2.1 NGS-Based Integration Services
6.2.2 MS-Based Integration Services
6.2.3 Bioinformatics Software-Assisted Services
6.2.4 Others
6.3 Market Segment by Technical Tool
6.3.1 World Integrated Multi-Omics Services Market Size by Technical Tool (2021-2026)
6.3.2 World Integrated Multi-Omics Services Market Size by Technical Tool (2027-2032)
6.3.3 World Integrated Multi-Omics Services Market Size Market Share by Technical Tool (2027-2032)
7 MARKET ANALYSIS BY SERVICE PROCESS STAGE
7.1 World Integrated Multi-Omics Services Market Size Overview by Service Process Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Process Stage
7.2.1 Sample Preparation & Sequencing Services
7.2.2 Data Integration & Analysis Services
7.2.3 Result Interpretation & Report Services
7.2.4 Customized Solution Design Services
7.2.5 Others
7.3 Market Segment by Service Process Stage
7.3.1 World Integrated Multi-Omics Services Market Size by Service Process Stage (2021-2026)
7.3.2 World Integrated Multi-Omics Services Market Size by Service Process Stage (2027-2032)
7.3.3 World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Integrated Multi-Omics Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Research
8.2.2 Precision Medicine
8.2.3 Crop Breeding
8.2.4 Environmental Microbial Monitoring
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Integrated Multi-Omics Services Market Size by Application (2021-2026)
8.3.2 World Integrated Multi-Omics Services Market Size by Application (2027-2032)
8.3.3 World Integrated Multi-Omics Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences
9.1.1 Azenta Life Sciences Details
9.1.2 Azenta Life Sciences Major Business
9.1.3 Azenta Life Sciences Integrated Multi-Omics Services Product and Services
9.1.4 Azenta Life Sciences Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences Recent Developments/Updates
9.1.6 Azenta Life Sciences Competitive Strengths & Weaknesses
9.2 Eurofins
9.2.1 Eurofins Details
9.2.2 Eurofins Major Business
9.2.3 Eurofins Integrated Multi-Omics Services Product and Services
9.2.4 Eurofins Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Eurofins Recent Developments/Updates
9.2.6 Eurofins Competitive Strengths & Weaknesses
9.3 Source BioScience
9.3.1 Source BioScience Details
9.3.2 Source BioScience Major Business
9.3.3 Source BioScience Integrated Multi-Omics Services Product and Services
9.3.4 Source BioScience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Source BioScience Recent Developments/Updates
9.3.6 Source BioScience Competitive Strengths & Weaknesses
9.4 Psomagen
9.4.1 Psomagen Details
9.4.2 Psomagen Major Business
9.4.3 Psomagen Integrated Multi-Omics Services Product and Services
9.4.4 Psomagen Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Psomagen Recent Developments/Updates
9.4.6 Psomagen Competitive Strengths & Weaknesses
9.5 Tempus
9.5.1 Tempus Details
9.5.2 Tempus Major Business
9.5.3 Tempus Integrated Multi-Omics Services Product and Services
9.5.4 Tempus Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Tempus Recent Developments/Updates
9.5.6 Tempus Competitive Strengths & Weaknesses
9.6 Evotec
9.6.1 Evotec Details
9.6.2 Evotec Major Business
9.6.3 Evotec Integrated Multi-Omics Services Product and Services
9.6.4 Evotec Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Evotec Recent Developments/Updates
9.6.6 Evotec Competitive Strengths & Weaknesses
9.7 Crown Bioscience
9.7.1 Crown Bioscience Details
9.7.2 Crown Bioscience Major Business
9.7.3 Crown Bioscience Integrated Multi-Omics Services Product and Services
9.7.4 Crown Bioscience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Crown Bioscience Recent Developments/Updates
9.7.6 Crown Bioscience Competitive Strengths & Weaknesses
9.8 Sapient
9.8.1 Sapient Details
9.8.2 Sapient Major Business
9.8.3 Sapient Integrated Multi-Omics Services Product and Services
9.8.4 Sapient Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sapient Recent Developments/Updates
9.8.6 Sapient Competitive Strengths & Weaknesses
9.9 Bruker Spatial Biology CRO Services
9.9.1 Bruker Spatial Biology CRO Services Details
9.9.2 Bruker Spatial Biology CRO Services Major Business
9.9.3 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product and Services
9.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Bruker Spatial Biology CRO Services Recent Developments/Updates
9.9.6 Bruker Spatial Biology CRO Services Competitive Strengths & Weaknesses
9.10 Advanced Cell Diagnostics (ACD)
9.10.1 Advanced Cell Diagnostics (ACD) Details
9.10.2 Advanced Cell Diagnostics (ACD) Major Business
9.10.3 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product and Services
9.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Advanced Cell Diagnostics (ACD) Recent Developments/Updates
9.10.6 Advanced Cell Diagnostics (ACD) Competitive Strengths & Weaknesses
9.11 Panome Bio
9.11.1 Panome Bio Details
9.11.2 Panome Bio Major Business
9.11.3 Panome Bio Integrated Multi-Omics Services Product and Services
9.11.4 Panome Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Panome Bio Recent Developments/Updates
9.11.6 Panome Bio Competitive Strengths & Weaknesses
9.12 RayBiotech
9.12.1 RayBiotech Details
9.12.2 RayBiotech Major Business
9.12.3 RayBiotech Integrated Multi-Omics Services Product and Services
9.12.4 RayBiotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 RayBiotech Recent Developments/Updates
9.12.6 RayBiotech Competitive Strengths & Weaknesses
9.13 Metware Biotechnology
9.13.1 Metware Biotechnology Details
9.13.2 Metware Biotechnology Major Business
9.13.3 Metware Biotechnology Integrated Multi-Omics Services Product and Services
9.13.4 Metware Biotechnology Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Metware Biotechnology Recent Developments/Updates
9.13.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.14 HaploX
9.14.1 HaploX Details
9.14.2 HaploX Major Business
9.14.3 HaploX Integrated Multi-Omics Services Product and Services
9.14.4 HaploX Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 HaploX Recent Developments/Updates
9.14.6 HaploX Competitive Strengths & Weaknesses
9.15 Creative Proteomics
9.15.1 Creative Proteomics Details
9.15.2 Creative Proteomics Major Business
9.15.3 Creative Proteomics Integrated Multi-Omics Services Product and Services
9.15.4 Creative Proteomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Creative Proteomics Recent Developments/Updates
9.15.6 Creative Proteomics Competitive Strengths & Weaknesses
9.16 CD Genomics
9.16.1 CD Genomics Details
9.16.2 CD Genomics Major Business
9.16.3 CD Genomics Integrated Multi-Omics Services Product and Services
9.16.4 CD Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 CD Genomics Recent Developments/Updates
9.16.6 CD Genomics Competitive Strengths & Weaknesses
9.17 Omics Empower
9.17.1 Omics Empower Details
9.17.2 Omics Empower Major Business
9.17.3 Omics Empower Integrated Multi-Omics Services Product and Services
9.17.4 Omics Empower Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Omics Empower Recent Developments/Updates
9.17.6 Omics Empower Competitive Strengths & Weaknesses
9.18 Cmbio
9.18.1 Cmbio Details
9.18.2 Cmbio Major Business
9.18.3 Cmbio Integrated Multi-Omics Services Product and Services
9.18.4 Cmbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Cmbio Recent Developments/Updates
9.18.6 Cmbio Competitive Strengths & Weaknesses
9.19 Dalton Bioanalytics
9.19.1 Dalton Bioanalytics Details
9.19.2 Dalton Bioanalytics Major Business
9.19.3 Dalton Bioanalytics Integrated Multi-Omics Services Product and Services
9.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Dalton Bioanalytics Recent Developments/Updates
9.19.6 Dalton Bioanalytics Competitive Strengths & Weaknesses
9.20 General Metabolics
9.20.1 General Metabolics Details
9.20.2 General Metabolics Major Business
9.20.3 General Metabolics Integrated Multi-Omics Services Product and Services
9.20.4 General Metabolics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 General Metabolics Recent Developments/Updates
9.20.6 General Metabolics Competitive Strengths & Weaknesses
9.21 Signios Bio
9.21.1 Signios Bio Details
9.21.2 Signios Bio Major Business
9.21.3 Signios Bio Integrated Multi-Omics Services Product and Services
9.21.4 Signios Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Signios Bio Recent Developments/Updates
9.21.6 Signios Bio Competitive Strengths & Weaknesses
9.22 Source Genomics
9.22.1 Source Genomics Details
9.22.2 Source Genomics Major Business
9.22.3 Source Genomics Integrated Multi-Omics Services Product and Services
9.22.4 Source Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Source Genomics Recent Developments/Updates
9.22.6 Source Genomics Competitive Strengths & Weaknesses
9.23 Genechem
9.23.1 Genechem Details
9.23.2 Genechem Major Business
9.23.3 Genechem Integrated Multi-Omics Services Product and Services
9.23.4 Genechem Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Genechem Recent Developments/Updates
9.23.6 Genechem Competitive Strengths & Weaknesses
9.24 BGI Genomics
9.24.1 BGI Genomics Details
9.24.2 BGI Genomics Major Business
9.24.3 BGI Genomics Integrated Multi-Omics Services Product and Services
9.24.4 BGI Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 BGI Genomics Recent Developments/Updates
9.24.6 BGI Genomics Competitive Strengths & Weaknesses
9.25 OE Biotech
9.25.1 OE Biotech Details
9.25.2 OE Biotech Major Business
9.25.3 OE Biotech Integrated Multi-Omics Services Product and Services
9.25.4 OE Biotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 OE Biotech Recent Developments/Updates
9.25.6 OE Biotech Competitive Strengths & Weaknesses
9.26 BMKGENE
9.26.1 BMKGENE Details
9.26.2 BMKGENE Major Business
9.26.3 BMKGENE Integrated Multi-Omics Services Product and Services
9.26.4 BMKGENE Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 BMKGENE Recent Developments/Updates
9.26.6 BMKGENE Competitive Strengths & Weaknesses
9.27 Majorbio
9.27.1 Majorbio Details
9.27.2 Majorbio Major Business
9.27.3 Majorbio Integrated Multi-Omics Services Product and Services
9.27.4 Majorbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Majorbio Recent Developments/Updates
9.27.6 Majorbio Competitive Strengths & Weaknesses
9.28 Wayen Biotechnologies
9.28.1 Wayen Biotechnologies Details
9.28.2 Wayen Biotechnologies Major Business
9.28.3 Wayen Biotechnologies Integrated Multi-Omics Services Product and Services
9.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Wayen Biotechnologies Recent Developments/Updates
9.28.6 Wayen Biotechnologies Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Integrated Multi-Omics Services Industry Chain
10.2 Integrated Multi-Omics Services Upstream Analysis
10.3 Integrated Multi-Omics Services Midstream Analysis
10.4 Integrated Multi-Omics Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Integrated Multi-Omics Services Introduction
1.2 World Integrated Multi-Omics Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Integrated Multi-Omics Services Total Market by Region (by Headquarter Location)
1.3.1 World Integrated Multi-Omics Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.3 China Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.4 Europe Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.5 Japan Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.6 South Korea Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.3.8 India Based Company Integrated Multi-Omics Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Integrated Multi-Omics Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Integrated Multi-Omics Services Consumption Value (2021-2032)
2.2 World Integrated Multi-Omics Services Consumption Value by Region
2.2.1 World Integrated Multi-Omics Services Consumption Value by Region (2021-2026)
2.2.2 World Integrated Multi-Omics Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Integrated Multi-Omics Services Consumption Value (2021-2032)
2.4 China Integrated Multi-Omics Services Consumption Value (2021-2032)
2.5 Europe Integrated Multi-Omics Services Consumption Value (2021-2032)
2.6 Japan Integrated Multi-Omics Services Consumption Value (2021-2032)
2.7 South Korea Integrated Multi-Omics Services Consumption Value (2021-2032)
2.8 ASEAN Integrated Multi-Omics Services Consumption Value (2021-2032)
2.9 India Integrated Multi-Omics Services Consumption Value (2021-2032)
3 WORLD INTEGRATED MULTI-OMICS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Integrated Multi-Omics Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Integrated Multi-Omics Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Integrated Multi-Omics Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Integrated Multi-Omics Services in 2025
3.3 Integrated Multi-Omics Services Company Evaluation Quadrant
3.4 Integrated Multi-Omics Services Market: Overall Company Footprint Analysis
3.4.1 Integrated Multi-Omics Services Market: Region Footprint
3.4.2 Integrated Multi-Omics Services Market: Company Product Type Footprint
3.4.3 Integrated Multi-Omics Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Integrated Multi-Omics Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Integrated Multi-Omics Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Integrated Multi-Omics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Integrated Multi-Omics Services Consumption Value Comparison
4.2.1 United States VS China: Integrated Multi-Omics Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Integrated Multi-Omics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Integrated Multi-Omics Services Companies and Market Share, 2021-2026
4.3.1 United States Based Integrated Multi-Omics Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Integrated Multi-Omics Services Revenue, (2021-2026)
4.4 China Based Companies Integrated Multi-Omics Services Revenue and Market Share, 2021-2026
4.4.1 China Based Integrated Multi-Omics Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Integrated Multi-Omics Services Revenue, (2021-2026)
4.5 Rest of World Based Integrated Multi-Omics Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Integrated Multi-Omics Services Revenue (2021-2026)
5 MARKET ANALYSIS BY OMICS INTEGRATION TYPE
5.1 World Integrated Multi-Omics Services Market Size Overview by Omics Integration Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Omics Integration Type
5.2.1 Dual-Omics Integration Services
5.2.2 Triple-Omics Integration Services
5.2.3 Quadruple & Above Multi-Omics Integration Services
5.3 Market Segment by Omics Integration Type
5.3.1 World Integrated Multi-Omics Services Market Size by Omics Integration Type (2021-2026)
5.3.2 World Integrated Multi-Omics Services Market Size by Omics Integration Type (2027-2032)
5.3.3 World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type (2027-2032)
6 MARKET ANALYSIS BY TECHNICAL TOOL
6.1 World Integrated Multi-Omics Services Market Size Overview by Technical Tool: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technical Tool
6.2.1 NGS-Based Integration Services
6.2.2 MS-Based Integration Services
6.2.3 Bioinformatics Software-Assisted Services
6.2.4 Others
6.3 Market Segment by Technical Tool
6.3.1 World Integrated Multi-Omics Services Market Size by Technical Tool (2021-2026)
6.3.2 World Integrated Multi-Omics Services Market Size by Technical Tool (2027-2032)
6.3.3 World Integrated Multi-Omics Services Market Size Market Share by Technical Tool (2027-2032)
7 MARKET ANALYSIS BY SERVICE PROCESS STAGE
7.1 World Integrated Multi-Omics Services Market Size Overview by Service Process Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Process Stage
7.2.1 Sample Preparation & Sequencing Services
7.2.2 Data Integration & Analysis Services
7.2.3 Result Interpretation & Report Services
7.2.4 Customized Solution Design Services
7.2.5 Others
7.3 Market Segment by Service Process Stage
7.3.1 World Integrated Multi-Omics Services Market Size by Service Process Stage (2021-2026)
7.3.2 World Integrated Multi-Omics Services Market Size by Service Process Stage (2027-2032)
7.3.3 World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Integrated Multi-Omics Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Research
8.2.2 Precision Medicine
8.2.3 Crop Breeding
8.2.4 Environmental Microbial Monitoring
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Integrated Multi-Omics Services Market Size by Application (2021-2026)
8.3.2 World Integrated Multi-Omics Services Market Size by Application (2027-2032)
8.3.3 World Integrated Multi-Omics Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences
9.1.1 Azenta Life Sciences Details
9.1.2 Azenta Life Sciences Major Business
9.1.3 Azenta Life Sciences Integrated Multi-Omics Services Product and Services
9.1.4 Azenta Life Sciences Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences Recent Developments/Updates
9.1.6 Azenta Life Sciences Competitive Strengths & Weaknesses
9.2 Eurofins
9.2.1 Eurofins Details
9.2.2 Eurofins Major Business
9.2.3 Eurofins Integrated Multi-Omics Services Product and Services
9.2.4 Eurofins Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Eurofins Recent Developments/Updates
9.2.6 Eurofins Competitive Strengths & Weaknesses
9.3 Source BioScience
9.3.1 Source BioScience Details
9.3.2 Source BioScience Major Business
9.3.3 Source BioScience Integrated Multi-Omics Services Product and Services
9.3.4 Source BioScience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Source BioScience Recent Developments/Updates
9.3.6 Source BioScience Competitive Strengths & Weaknesses
9.4 Psomagen
9.4.1 Psomagen Details
9.4.2 Psomagen Major Business
9.4.3 Psomagen Integrated Multi-Omics Services Product and Services
9.4.4 Psomagen Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Psomagen Recent Developments/Updates
9.4.6 Psomagen Competitive Strengths & Weaknesses
9.5 Tempus
9.5.1 Tempus Details
9.5.2 Tempus Major Business
9.5.3 Tempus Integrated Multi-Omics Services Product and Services
9.5.4 Tempus Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Tempus Recent Developments/Updates
9.5.6 Tempus Competitive Strengths & Weaknesses
9.6 Evotec
9.6.1 Evotec Details
9.6.2 Evotec Major Business
9.6.3 Evotec Integrated Multi-Omics Services Product and Services
9.6.4 Evotec Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Evotec Recent Developments/Updates
9.6.6 Evotec Competitive Strengths & Weaknesses
9.7 Crown Bioscience
9.7.1 Crown Bioscience Details
9.7.2 Crown Bioscience Major Business
9.7.3 Crown Bioscience Integrated Multi-Omics Services Product and Services
9.7.4 Crown Bioscience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Crown Bioscience Recent Developments/Updates
9.7.6 Crown Bioscience Competitive Strengths & Weaknesses
9.8 Sapient
9.8.1 Sapient Details
9.8.2 Sapient Major Business
9.8.3 Sapient Integrated Multi-Omics Services Product and Services
9.8.4 Sapient Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sapient Recent Developments/Updates
9.8.6 Sapient Competitive Strengths & Weaknesses
9.9 Bruker Spatial Biology CRO Services
9.9.1 Bruker Spatial Biology CRO Services Details
9.9.2 Bruker Spatial Biology CRO Services Major Business
9.9.3 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product and Services
9.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Bruker Spatial Biology CRO Services Recent Developments/Updates
9.9.6 Bruker Spatial Biology CRO Services Competitive Strengths & Weaknesses
9.10 Advanced Cell Diagnostics (ACD)
9.10.1 Advanced Cell Diagnostics (ACD) Details
9.10.2 Advanced Cell Diagnostics (ACD) Major Business
9.10.3 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product and Services
9.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Advanced Cell Diagnostics (ACD) Recent Developments/Updates
9.10.6 Advanced Cell Diagnostics (ACD) Competitive Strengths & Weaknesses
9.11 Panome Bio
9.11.1 Panome Bio Details
9.11.2 Panome Bio Major Business
9.11.3 Panome Bio Integrated Multi-Omics Services Product and Services
9.11.4 Panome Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Panome Bio Recent Developments/Updates
9.11.6 Panome Bio Competitive Strengths & Weaknesses
9.12 RayBiotech
9.12.1 RayBiotech Details
9.12.2 RayBiotech Major Business
9.12.3 RayBiotech Integrated Multi-Omics Services Product and Services
9.12.4 RayBiotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 RayBiotech Recent Developments/Updates
9.12.6 RayBiotech Competitive Strengths & Weaknesses
9.13 Metware Biotechnology
9.13.1 Metware Biotechnology Details
9.13.2 Metware Biotechnology Major Business
9.13.3 Metware Biotechnology Integrated Multi-Omics Services Product and Services
9.13.4 Metware Biotechnology Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Metware Biotechnology Recent Developments/Updates
9.13.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.14 HaploX
9.14.1 HaploX Details
9.14.2 HaploX Major Business
9.14.3 HaploX Integrated Multi-Omics Services Product and Services
9.14.4 HaploX Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 HaploX Recent Developments/Updates
9.14.6 HaploX Competitive Strengths & Weaknesses
9.15 Creative Proteomics
9.15.1 Creative Proteomics Details
9.15.2 Creative Proteomics Major Business
9.15.3 Creative Proteomics Integrated Multi-Omics Services Product and Services
9.15.4 Creative Proteomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Creative Proteomics Recent Developments/Updates
9.15.6 Creative Proteomics Competitive Strengths & Weaknesses
9.16 CD Genomics
9.16.1 CD Genomics Details
9.16.2 CD Genomics Major Business
9.16.3 CD Genomics Integrated Multi-Omics Services Product and Services
9.16.4 CD Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 CD Genomics Recent Developments/Updates
9.16.6 CD Genomics Competitive Strengths & Weaknesses
9.17 Omics Empower
9.17.1 Omics Empower Details
9.17.2 Omics Empower Major Business
9.17.3 Omics Empower Integrated Multi-Omics Services Product and Services
9.17.4 Omics Empower Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Omics Empower Recent Developments/Updates
9.17.6 Omics Empower Competitive Strengths & Weaknesses
9.18 Cmbio
9.18.1 Cmbio Details
9.18.2 Cmbio Major Business
9.18.3 Cmbio Integrated Multi-Omics Services Product and Services
9.18.4 Cmbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Cmbio Recent Developments/Updates
9.18.6 Cmbio Competitive Strengths & Weaknesses
9.19 Dalton Bioanalytics
9.19.1 Dalton Bioanalytics Details
9.19.2 Dalton Bioanalytics Major Business
9.19.3 Dalton Bioanalytics Integrated Multi-Omics Services Product and Services
9.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Dalton Bioanalytics Recent Developments/Updates
9.19.6 Dalton Bioanalytics Competitive Strengths & Weaknesses
9.20 General Metabolics
9.20.1 General Metabolics Details
9.20.2 General Metabolics Major Business
9.20.3 General Metabolics Integrated Multi-Omics Services Product and Services
9.20.4 General Metabolics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 General Metabolics Recent Developments/Updates
9.20.6 General Metabolics Competitive Strengths & Weaknesses
9.21 Signios Bio
9.21.1 Signios Bio Details
9.21.2 Signios Bio Major Business
9.21.3 Signios Bio Integrated Multi-Omics Services Product and Services
9.21.4 Signios Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Signios Bio Recent Developments/Updates
9.21.6 Signios Bio Competitive Strengths & Weaknesses
9.22 Source Genomics
9.22.1 Source Genomics Details
9.22.2 Source Genomics Major Business
9.22.3 Source Genomics Integrated Multi-Omics Services Product and Services
9.22.4 Source Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Source Genomics Recent Developments/Updates
9.22.6 Source Genomics Competitive Strengths & Weaknesses
9.23 Genechem
9.23.1 Genechem Details
9.23.2 Genechem Major Business
9.23.3 Genechem Integrated Multi-Omics Services Product and Services
9.23.4 Genechem Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Genechem Recent Developments/Updates
9.23.6 Genechem Competitive Strengths & Weaknesses
9.24 BGI Genomics
9.24.1 BGI Genomics Details
9.24.2 BGI Genomics Major Business
9.24.3 BGI Genomics Integrated Multi-Omics Services Product and Services
9.24.4 BGI Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 BGI Genomics Recent Developments/Updates
9.24.6 BGI Genomics Competitive Strengths & Weaknesses
9.25 OE Biotech
9.25.1 OE Biotech Details
9.25.2 OE Biotech Major Business
9.25.3 OE Biotech Integrated Multi-Omics Services Product and Services
9.25.4 OE Biotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 OE Biotech Recent Developments/Updates
9.25.6 OE Biotech Competitive Strengths & Weaknesses
9.26 BMKGENE
9.26.1 BMKGENE Details
9.26.2 BMKGENE Major Business
9.26.3 BMKGENE Integrated Multi-Omics Services Product and Services
9.26.4 BMKGENE Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 BMKGENE Recent Developments/Updates
9.26.6 BMKGENE Competitive Strengths & Weaknesses
9.27 Majorbio
9.27.1 Majorbio Details
9.27.2 Majorbio Major Business
9.27.3 Majorbio Integrated Multi-Omics Services Product and Services
9.27.4 Majorbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Majorbio Recent Developments/Updates
9.27.6 Majorbio Competitive Strengths & Weaknesses
9.28 Wayen Biotechnologies
9.28.1 Wayen Biotechnologies Details
9.28.2 Wayen Biotechnologies Major Business
9.28.3 Wayen Biotechnologies Integrated Multi-Omics Services Product and Services
9.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Wayen Biotechnologies Recent Developments/Updates
9.28.6 Wayen Biotechnologies Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Integrated Multi-Omics Services Industry Chain
10.2 Integrated Multi-Omics Services Upstream Analysis
10.3 Integrated Multi-Omics Services Midstream Analysis
10.4 Integrated Multi-Omics Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Integrated Multi-Omics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Integrated Multi-Omics Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Integrated Multi-Omics Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Integrated Multi-Omics Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Integrated Multi-Omics Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Integrated Multi-Omics Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Integrated Multi-Omics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Integrated Multi-Omics Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Integrated Multi-Omics Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Integrated Multi-Omics Services Players in 2025
Table 12. World Integrated Multi-Omics Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Integrated Multi-Omics Services Company Evaluation Quadrant
Table 14. Head Office of Key Integrated Multi-Omics Services Players
Table 15. Integrated Multi-Omics Services Market: Company Product Type Footprint
Table 16. Integrated Multi-Omics Services Market: Company Product Application Footprint
Table 17. Integrated Multi-Omics Services Mergers & Acquisitions Activity
Table 18. United States VS China Integrated Multi-Omics Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Integrated Multi-Omics Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Integrated Multi-Omics Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Integrated Multi-Omics Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 23. China Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Integrated Multi-Omics Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Integrated Multi-Omics Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 29. World Integrated Multi-Omics Services Market Size by Omics Integration Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Integrated Multi-Omics Services Market Size Value by Omics Integration Type (2021-2026) & (USD Million)
Table 31. World Integrated Multi-Omics Services Market Size by Omics Integration Type (2027-2032) & (USD Million)
Table 32. World Integrated Multi-Omics Services Market Size by Technical Tool, (USD Million), 2021 & 2025 & 2032
Table 33. World Integrated Multi-Omics Services Market Size Value by Technical Tool (2021-2026) & (USD Million)
Table 34. World Integrated Multi-Omics Services Market Size by Technical Tool (2027-2032) & (USD Million)
Table 35. World Integrated Multi-Omics Services Market Size by Service Process Stage, (USD Million), 2021 & 2025 & 2032
Table 36. World Integrated Multi-Omics Services Market Size Value by Service Process Stage (2021-2026) & (USD Million)
Table 37. World Integrated Multi-Omics Services Market Size by Service Process Stage (2027-2032) & (USD Million)
Table 38. World Integrated Multi-Omics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Integrated Multi-Omics Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Integrated Multi-Omics Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences Major Business
Table 43. Azenta Life Sciences Integrated Multi-Omics Services Product and Services
Table 44. Azenta Life Sciences Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences Recent Developments/Updates
Table 46. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 47. Eurofins Basic Information, Manufacturing Base and Competitors
Table 48. Eurofins Major Business
Table 49. Eurofins Integrated Multi-Omics Services Product and Services
Table 50. Eurofins Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Eurofins Recent Developments/Updates
Table 52. Eurofins Competitive Strengths & Weaknesses
Table 53. Source BioScience Basic Information, Manufacturing Base and Competitors
Table 54. Source BioScience Major Business
Table 55. Source BioScience Integrated Multi-Omics Services Product and Services
Table 56. Source BioScience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Source BioScience Recent Developments/Updates
Table 58. Source BioScience Competitive Strengths & Weaknesses
Table 59. Psomagen Basic Information, Manufacturing Base and Competitors
Table 60. Psomagen Major Business
Table 61. Psomagen Integrated Multi-Omics Services Product and Services
Table 62. Psomagen Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Psomagen Recent Developments/Updates
Table 64. Psomagen Competitive Strengths & Weaknesses
Table 65. Tempus Basic Information, Manufacturing Base and Competitors
Table 66. Tempus Major Business
Table 67. Tempus Integrated Multi-Omics Services Product and Services
Table 68. Tempus Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Tempus Recent Developments/Updates
Table 70. Tempus Competitive Strengths & Weaknesses
Table 71. Evotec Basic Information, Manufacturing Base and Competitors
Table 72. Evotec Major Business
Table 73. Evotec Integrated Multi-Omics Services Product and Services
Table 74. Evotec Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Evotec Recent Developments/Updates
Table 76. Evotec Competitive Strengths & Weaknesses
Table 77. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 78. Crown Bioscience Major Business
Table 79. Crown Bioscience Integrated Multi-Omics Services Product and Services
Table 80. Crown Bioscience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Crown Bioscience Recent Developments/Updates
Table 82. Crown Bioscience Competitive Strengths & Weaknesses
Table 83. Sapient Basic Information, Manufacturing Base and Competitors
Table 84. Sapient Major Business
Table 85. Sapient Integrated Multi-Omics Services Product and Services
Table 86. Sapient Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sapient Recent Developments/Updates
Table 88. Sapient Competitive Strengths & Weaknesses
Table 89. Bruker Spatial Biology CRO Services Basic Information, Manufacturing Base and Competitors
Table 90. Bruker Spatial Biology CRO Services Major Business
Table 91. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product and Services
Table 92. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Bruker Spatial Biology CRO Services Recent Developments/Updates
Table 94. Bruker Spatial Biology CRO Services Competitive Strengths & Weaknesses
Table 95. Advanced Cell Diagnostics (ACD) Basic Information, Manufacturing Base and Competitors
Table 96. Advanced Cell Diagnostics (ACD) Major Business
Table 97. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product and Services
Table 98. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Advanced Cell Diagnostics (ACD) Recent Developments/Updates
Table 100. Advanced Cell Diagnostics (ACD) Competitive Strengths & Weaknesses
Table 101. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 102. Panome Bio Major Business
Table 103. Panome Bio Integrated Multi-Omics Services Product and Services
Table 104. Panome Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Panome Bio Recent Developments/Updates
Table 106. Panome Bio Competitive Strengths & Weaknesses
Table 107. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 108. RayBiotech Major Business
Table 109. RayBiotech Integrated Multi-Omics Services Product and Services
Table 110. RayBiotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. RayBiotech Recent Developments/Updates
Table 112. RayBiotech Competitive Strengths & Weaknesses
Table 113. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 114. Metware Biotechnology Major Business
Table 115. Metware Biotechnology Integrated Multi-Omics Services Product and Services
Table 116. Metware Biotechnology Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Metware Biotechnology Recent Developments/Updates
Table 118. Metware Biotechnology Competitive Strengths & Weaknesses
Table 119. HaploX Basic Information, Manufacturing Base and Competitors
Table 120. HaploX Major Business
Table 121. HaploX Integrated Multi-Omics Services Product and Services
Table 122. HaploX Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. HaploX Recent Developments/Updates
Table 124. HaploX Competitive Strengths & Weaknesses
Table 125. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 126. Creative Proteomics Major Business
Table 127. Creative Proteomics Integrated Multi-Omics Services Product and Services
Table 128. Creative Proteomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Creative Proteomics Recent Developments/Updates
Table 130. Creative Proteomics Competitive Strengths & Weaknesses
Table 131. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 132. CD Genomics Major Business
Table 133. CD Genomics Integrated Multi-Omics Services Product and Services
Table 134. CD Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. CD Genomics Recent Developments/Updates
Table 136. CD Genomics Competitive Strengths & Weaknesses
Table 137. Omics Empower Basic Information, Manufacturing Base and Competitors
Table 138. Omics Empower Major Business
Table 139. Omics Empower Integrated Multi-Omics Services Product and Services
Table 140. Omics Empower Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Omics Empower Recent Developments/Updates
Table 142. Omics Empower Competitive Strengths & Weaknesses
Table 143. Cmbio Basic Information, Manufacturing Base and Competitors
Table 144. Cmbio Major Business
Table 145. Cmbio Integrated Multi-Omics Services Product and Services
Table 146. Cmbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Cmbio Recent Developments/Updates
Table 148. Cmbio Competitive Strengths & Weaknesses
Table 149. Dalton Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 150. Dalton Bioanalytics Major Business
Table 151. Dalton Bioanalytics Integrated Multi-Omics Services Product and Services
Table 152. Dalton Bioanalytics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Dalton Bioanalytics Recent Developments/Updates
Table 154. Dalton Bioanalytics Competitive Strengths & Weaknesses
Table 155. General Metabolics Basic Information, Manufacturing Base and Competitors
Table 156. General Metabolics Major Business
Table 157. General Metabolics Integrated Multi-Omics Services Product and Services
Table 158. General Metabolics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. General Metabolics Recent Developments/Updates
Table 160. General Metabolics Competitive Strengths & Weaknesses
Table 161. Signios Bio Basic Information, Manufacturing Base and Competitors
Table 162. Signios Bio Major Business
Table 163. Signios Bio Integrated Multi-Omics Services Product and Services
Table 164. Signios Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Signios Bio Recent Developments/Updates
Table 166. Signios Bio Competitive Strengths & Weaknesses
Table 167. Source Genomics Basic Information, Manufacturing Base and Competitors
Table 168. Source Genomics Major Business
Table 169. Source Genomics Integrated Multi-Omics Services Product and Services
Table 170. Source Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Source Genomics Recent Developments/Updates
Table 172. Source Genomics Competitive Strengths & Weaknesses
Table 173. Genechem Basic Information, Manufacturing Base and Competitors
Table 174. Genechem Major Business
Table 175. Genechem Integrated Multi-Omics Services Product and Services
Table 176. Genechem Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Genechem Recent Developments/Updates
Table 178. Genechem Competitive Strengths & Weaknesses
Table 179. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 180. BGI Genomics Major Business
Table 181. BGI Genomics Integrated Multi-Omics Services Product and Services
Table 182. BGI Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. BGI Genomics Recent Developments/Updates
Table 184. BGI Genomics Competitive Strengths & Weaknesses
Table 185. OE Biotech Basic Information, Manufacturing Base and Competitors
Table 186. OE Biotech Major Business
Table 187. OE Biotech Integrated Multi-Omics Services Product and Services
Table 188. OE Biotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. OE Biotech Recent Developments/Updates
Table 190. OE Biotech Competitive Strengths & Weaknesses
Table 191. BMKGENE Basic Information, Manufacturing Base and Competitors
Table 192. BMKGENE Major Business
Table 193. BMKGENE Integrated Multi-Omics Services Product and Services
Table 194. BMKGENE Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. BMKGENE Recent Developments/Updates
Table 196. BMKGENE Competitive Strengths & Weaknesses
Table 197. Majorbio Basic Information, Manufacturing Base and Competitors
Table 198. Majorbio Major Business
Table 199. Majorbio Integrated Multi-Omics Services Product and Services
Table 200. Majorbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Majorbio Recent Developments/Updates
Table 202. Majorbio Competitive Strengths & Weaknesses
Table 203. Wayen Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 204. Wayen Biotechnologies Major Business
Table 205. Wayen Biotechnologies Integrated Multi-Omics Services Product and Services
Table 206. Wayen Biotechnologies Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Wayen Biotechnologies Recent Developments/Updates
Table 208. Wayen Biotechnologies Competitive Strengths & Weaknesses
Table 209. Global Key Players of Integrated Multi-Omics Services Upstream (Raw Materials)
Table 210. Global Integrated Multi-Omics Services Typical Customers
Table 1. World Integrated Multi-Omics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Integrated Multi-Omics Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Integrated Multi-Omics Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Integrated Multi-Omics Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Integrated Multi-Omics Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Integrated Multi-Omics Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Integrated Multi-Omics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Integrated Multi-Omics Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Integrated Multi-Omics Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Integrated Multi-Omics Services Players in 2025
Table 12. World Integrated Multi-Omics Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Integrated Multi-Omics Services Company Evaluation Quadrant
Table 14. Head Office of Key Integrated Multi-Omics Services Players
Table 15. Integrated Multi-Omics Services Market: Company Product Type Footprint
Table 16. Integrated Multi-Omics Services Market: Company Product Application Footprint
Table 17. Integrated Multi-Omics Services Mergers & Acquisitions Activity
Table 18. United States VS China Integrated Multi-Omics Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Integrated Multi-Omics Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Integrated Multi-Omics Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Integrated Multi-Omics Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 23. China Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Integrated Multi-Omics Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Integrated Multi-Omics Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Integrated Multi-Omics Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Integrated Multi-Omics Services Revenue Market Share (2021-2026)
Table 29. World Integrated Multi-Omics Services Market Size by Omics Integration Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Integrated Multi-Omics Services Market Size Value by Omics Integration Type (2021-2026) & (USD Million)
Table 31. World Integrated Multi-Omics Services Market Size by Omics Integration Type (2027-2032) & (USD Million)
Table 32. World Integrated Multi-Omics Services Market Size by Technical Tool, (USD Million), 2021 & 2025 & 2032
Table 33. World Integrated Multi-Omics Services Market Size Value by Technical Tool (2021-2026) & (USD Million)
Table 34. World Integrated Multi-Omics Services Market Size by Technical Tool (2027-2032) & (USD Million)
Table 35. World Integrated Multi-Omics Services Market Size by Service Process Stage, (USD Million), 2021 & 2025 & 2032
Table 36. World Integrated Multi-Omics Services Market Size Value by Service Process Stage (2021-2026) & (USD Million)
Table 37. World Integrated Multi-Omics Services Market Size by Service Process Stage (2027-2032) & (USD Million)
Table 38. World Integrated Multi-Omics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Integrated Multi-Omics Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Integrated Multi-Omics Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences Major Business
Table 43. Azenta Life Sciences Integrated Multi-Omics Services Product and Services
Table 44. Azenta Life Sciences Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences Recent Developments/Updates
Table 46. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 47. Eurofins Basic Information, Manufacturing Base and Competitors
Table 48. Eurofins Major Business
Table 49. Eurofins Integrated Multi-Omics Services Product and Services
Table 50. Eurofins Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Eurofins Recent Developments/Updates
Table 52. Eurofins Competitive Strengths & Weaknesses
Table 53. Source BioScience Basic Information, Manufacturing Base and Competitors
Table 54. Source BioScience Major Business
Table 55. Source BioScience Integrated Multi-Omics Services Product and Services
Table 56. Source BioScience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Source BioScience Recent Developments/Updates
Table 58. Source BioScience Competitive Strengths & Weaknesses
Table 59. Psomagen Basic Information, Manufacturing Base and Competitors
Table 60. Psomagen Major Business
Table 61. Psomagen Integrated Multi-Omics Services Product and Services
Table 62. Psomagen Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Psomagen Recent Developments/Updates
Table 64. Psomagen Competitive Strengths & Weaknesses
Table 65. Tempus Basic Information, Manufacturing Base and Competitors
Table 66. Tempus Major Business
Table 67. Tempus Integrated Multi-Omics Services Product and Services
Table 68. Tempus Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Tempus Recent Developments/Updates
Table 70. Tempus Competitive Strengths & Weaknesses
Table 71. Evotec Basic Information, Manufacturing Base and Competitors
Table 72. Evotec Major Business
Table 73. Evotec Integrated Multi-Omics Services Product and Services
Table 74. Evotec Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Evotec Recent Developments/Updates
Table 76. Evotec Competitive Strengths & Weaknesses
Table 77. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 78. Crown Bioscience Major Business
Table 79. Crown Bioscience Integrated Multi-Omics Services Product and Services
Table 80. Crown Bioscience Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Crown Bioscience Recent Developments/Updates
Table 82. Crown Bioscience Competitive Strengths & Weaknesses
Table 83. Sapient Basic Information, Manufacturing Base and Competitors
Table 84. Sapient Major Business
Table 85. Sapient Integrated Multi-Omics Services Product and Services
Table 86. Sapient Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sapient Recent Developments/Updates
Table 88. Sapient Competitive Strengths & Weaknesses
Table 89. Bruker Spatial Biology CRO Services Basic Information, Manufacturing Base and Competitors
Table 90. Bruker Spatial Biology CRO Services Major Business
Table 91. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product and Services
Table 92. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Bruker Spatial Biology CRO Services Recent Developments/Updates
Table 94. Bruker Spatial Biology CRO Services Competitive Strengths & Weaknesses
Table 95. Advanced Cell Diagnostics (ACD) Basic Information, Manufacturing Base and Competitors
Table 96. Advanced Cell Diagnostics (ACD) Major Business
Table 97. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product and Services
Table 98. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Advanced Cell Diagnostics (ACD) Recent Developments/Updates
Table 100. Advanced Cell Diagnostics (ACD) Competitive Strengths & Weaknesses
Table 101. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 102. Panome Bio Major Business
Table 103. Panome Bio Integrated Multi-Omics Services Product and Services
Table 104. Panome Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Panome Bio Recent Developments/Updates
Table 106. Panome Bio Competitive Strengths & Weaknesses
Table 107. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 108. RayBiotech Major Business
Table 109. RayBiotech Integrated Multi-Omics Services Product and Services
Table 110. RayBiotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. RayBiotech Recent Developments/Updates
Table 112. RayBiotech Competitive Strengths & Weaknesses
Table 113. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 114. Metware Biotechnology Major Business
Table 115. Metware Biotechnology Integrated Multi-Omics Services Product and Services
Table 116. Metware Biotechnology Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Metware Biotechnology Recent Developments/Updates
Table 118. Metware Biotechnology Competitive Strengths & Weaknesses
Table 119. HaploX Basic Information, Manufacturing Base and Competitors
Table 120. HaploX Major Business
Table 121. HaploX Integrated Multi-Omics Services Product and Services
Table 122. HaploX Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. HaploX Recent Developments/Updates
Table 124. HaploX Competitive Strengths & Weaknesses
Table 125. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 126. Creative Proteomics Major Business
Table 127. Creative Proteomics Integrated Multi-Omics Services Product and Services
Table 128. Creative Proteomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Creative Proteomics Recent Developments/Updates
Table 130. Creative Proteomics Competitive Strengths & Weaknesses
Table 131. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 132. CD Genomics Major Business
Table 133. CD Genomics Integrated Multi-Omics Services Product and Services
Table 134. CD Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. CD Genomics Recent Developments/Updates
Table 136. CD Genomics Competitive Strengths & Weaknesses
Table 137. Omics Empower Basic Information, Manufacturing Base and Competitors
Table 138. Omics Empower Major Business
Table 139. Omics Empower Integrated Multi-Omics Services Product and Services
Table 140. Omics Empower Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Omics Empower Recent Developments/Updates
Table 142. Omics Empower Competitive Strengths & Weaknesses
Table 143. Cmbio Basic Information, Manufacturing Base and Competitors
Table 144. Cmbio Major Business
Table 145. Cmbio Integrated Multi-Omics Services Product and Services
Table 146. Cmbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Cmbio Recent Developments/Updates
Table 148. Cmbio Competitive Strengths & Weaknesses
Table 149. Dalton Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 150. Dalton Bioanalytics Major Business
Table 151. Dalton Bioanalytics Integrated Multi-Omics Services Product and Services
Table 152. Dalton Bioanalytics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Dalton Bioanalytics Recent Developments/Updates
Table 154. Dalton Bioanalytics Competitive Strengths & Weaknesses
Table 155. General Metabolics Basic Information, Manufacturing Base and Competitors
Table 156. General Metabolics Major Business
Table 157. General Metabolics Integrated Multi-Omics Services Product and Services
Table 158. General Metabolics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. General Metabolics Recent Developments/Updates
Table 160. General Metabolics Competitive Strengths & Weaknesses
Table 161. Signios Bio Basic Information, Manufacturing Base and Competitors
Table 162. Signios Bio Major Business
Table 163. Signios Bio Integrated Multi-Omics Services Product and Services
Table 164. Signios Bio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Signios Bio Recent Developments/Updates
Table 166. Signios Bio Competitive Strengths & Weaknesses
Table 167. Source Genomics Basic Information, Manufacturing Base and Competitors
Table 168. Source Genomics Major Business
Table 169. Source Genomics Integrated Multi-Omics Services Product and Services
Table 170. Source Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Source Genomics Recent Developments/Updates
Table 172. Source Genomics Competitive Strengths & Weaknesses
Table 173. Genechem Basic Information, Manufacturing Base and Competitors
Table 174. Genechem Major Business
Table 175. Genechem Integrated Multi-Omics Services Product and Services
Table 176. Genechem Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Genechem Recent Developments/Updates
Table 178. Genechem Competitive Strengths & Weaknesses
Table 179. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 180. BGI Genomics Major Business
Table 181. BGI Genomics Integrated Multi-Omics Services Product and Services
Table 182. BGI Genomics Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. BGI Genomics Recent Developments/Updates
Table 184. BGI Genomics Competitive Strengths & Weaknesses
Table 185. OE Biotech Basic Information, Manufacturing Base and Competitors
Table 186. OE Biotech Major Business
Table 187. OE Biotech Integrated Multi-Omics Services Product and Services
Table 188. OE Biotech Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. OE Biotech Recent Developments/Updates
Table 190. OE Biotech Competitive Strengths & Weaknesses
Table 191. BMKGENE Basic Information, Manufacturing Base and Competitors
Table 192. BMKGENE Major Business
Table 193. BMKGENE Integrated Multi-Omics Services Product and Services
Table 194. BMKGENE Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. BMKGENE Recent Developments/Updates
Table 196. BMKGENE Competitive Strengths & Weaknesses
Table 197. Majorbio Basic Information, Manufacturing Base and Competitors
Table 198. Majorbio Major Business
Table 199. Majorbio Integrated Multi-Omics Services Product and Services
Table 200. Majorbio Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Majorbio Recent Developments/Updates
Table 202. Majorbio Competitive Strengths & Weaknesses
Table 203. Wayen Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 204. Wayen Biotechnologies Major Business
Table 205. Wayen Biotechnologies Integrated Multi-Omics Services Product and Services
Table 206. Wayen Biotechnologies Integrated Multi-Omics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Wayen Biotechnologies Recent Developments/Updates
Table 208. Wayen Biotechnologies Competitive Strengths & Weaknesses
Table 209. Global Key Players of Integrated Multi-Omics Services Upstream (Raw Materials)
Table 210. Global Integrated Multi-Omics Services Typical Customers
LIST OF FIGURES
Figure 1. Integrated Multi-Omics Services Picture
Figure 2. World Integrated Multi-Omics Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Integrated Multi-Omics Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Integrated Multi-Omics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Integrated Multi-Omics Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 13. Integrated Multi-Omics Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Integrated Multi-Omics Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Integrated Multi-Omics Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Integrated Multi-Omics Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Integrated Multi-Omics Services Markets in 2025
Figure 27. United States VS China: Integrated Multi-Omics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Integrated Multi-Omics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Integrated Multi-Omics Services Market Size by Omics Integration Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type in 2025
Figure 31. Dual-Omics Integration Services
Figure 32. Triple-Omics Integration Services
Figure 33. Quadruple & Above Multi-Omics Integration Services
Figure 34. World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type (2021-2032)
Figure 35. World Integrated Multi-Omics Services Market Size by Technical Tool, (USD Million), 2021 & 2025 & 2032
Figure 36. World Integrated Multi-Omics Services Market Size Market Share by Technical Tool in 2025
Figure 37. NGS-Based Integration Services
Figure 38. MS-Based Integration Services
Figure 39. Bioinformatics Software-Assisted Services
Figure 40. Others
Figure 41. World Integrated Multi-Omics Services Market Size Market Share by Technical Tool (2021-2032)
Figure 42. World Integrated Multi-Omics Services Market Size by Service Process Stage, (USD Million), 2021 & 2025 & 2032
Figure 43. World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage in 2025
Figure 44. Sample Preparation & Sequencing Services
Figure 45. Data Integration & Analysis Services
Figure 46. Result Interpretation & Report Services
Figure 47. Customized Solution Design Services
Figure 48. Others
Figure 49. World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage (2021-2032)
Figure 50. World Integrated Multi-Omics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Integrated Multi-Omics Services Market Size Market Share by Application in 2025
Figure 52. Disease Research
Figure 53. Precision Medicine
Figure 54. Crop Breeding
Figure 55. Environmental Microbial Monitoring
Figure 56. Others
Figure 57. World Integrated Multi-Omics Services Market Size Market Share by Application (2021-2032)
Figure 58. Integrated Multi-Omics Services Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. Integrated Multi-Omics Services Picture
Figure 2. World Integrated Multi-Omics Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Integrated Multi-Omics Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Integrated Multi-Omics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Integrated Multi-Omics Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Integrated Multi-Omics Services Revenue (2021-2032) & (USD Million)
Figure 13. Integrated Multi-Omics Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Integrated Multi-Omics Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Integrated Multi-Omics Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Integrated Multi-Omics Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Integrated Multi-Omics Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Integrated Multi-Omics Services Markets in 2025
Figure 27. United States VS China: Integrated Multi-Omics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Integrated Multi-Omics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Integrated Multi-Omics Services Market Size by Omics Integration Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type in 2025
Figure 31. Dual-Omics Integration Services
Figure 32. Triple-Omics Integration Services
Figure 33. Quadruple & Above Multi-Omics Integration Services
Figure 34. World Integrated Multi-Omics Services Market Size Market Share by Omics Integration Type (2021-2032)
Figure 35. World Integrated Multi-Omics Services Market Size by Technical Tool, (USD Million), 2021 & 2025 & 2032
Figure 36. World Integrated Multi-Omics Services Market Size Market Share by Technical Tool in 2025
Figure 37. NGS-Based Integration Services
Figure 38. MS-Based Integration Services
Figure 39. Bioinformatics Software-Assisted Services
Figure 40. Others
Figure 41. World Integrated Multi-Omics Services Market Size Market Share by Technical Tool (2021-2032)
Figure 42. World Integrated Multi-Omics Services Market Size by Service Process Stage, (USD Million), 2021 & 2025 & 2032
Figure 43. World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage in 2025
Figure 44. Sample Preparation & Sequencing Services
Figure 45. Data Integration & Analysis Services
Figure 46. Result Interpretation & Report Services
Figure 47. Customized Solution Design Services
Figure 48. Others
Figure 49. World Integrated Multi-Omics Services Market Size Market Share by Service Process Stage (2021-2032)
Figure 50. World Integrated Multi-Omics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Integrated Multi-Omics Services Market Size Market Share by Application in 2025
Figure 52. Disease Research
Figure 53. Precision Medicine
Figure 54. Crop Breeding
Figure 55. Environmental Microbial Monitoring
Figure 56. Others
Figure 57. World Integrated Multi-Omics Services Market Size Market Share by Application (2021-2032)
Figure 58. Integrated Multi-Omics Services Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
